CAMBRIDGE, Mass., Nov. 01, 2021 (GLOBE NEWSWIRE) -- Cerevel Therapeutics (Nasdaq: CERE), a company dedicated to unraveling the mysteries of the brain to treat neuroscience diseases, announced that it will participate in four upcoming virtual investor conferences during the months of November and December.
Event:
Virtual Guggenheim 3rd Annual Neuro/Immunology Conference
Date:
November 15, 2021
Format:
One-on-one meetings with members of the investor relations team
Event:
Stifel 2021 Virtual Healthcare Conference
Date:
November 16, 2021
Format:
Fireside chat with Chairperson and CEO Tony Coles, M.D.
One-on-one meetings with members of the management team
Time:
8:40 a.m. ET
Event:
Jefferies London Healthcare Conference
Date:
November 18, 2021
Format:
One-on-one meetings with members of the management team
Event:
Evercore ISI HealthCONx Conference
Date:
December 1, 2021
Format:
Fireside chat with Chairperson and CEO Tony Coles, M.D.
One-on-one meetings with members of the management team
Time:
9:40 a.m. ET
Live audio webcasts of the virtual conference fireside chats can be accessed on the investor relations section of the Cerevel Therapeutics website here. Replays will also be available in the same section of the companys website.
About Cerevel TherapeuticsCerevel Therapeutics is dedicated to unraveling the mysteries of the brain to treat neuroscience diseases. The company is tackling diseases with a targeted approach to neuroscience that combines expertise in neurocircuitry with a focus on receptor selectivity. Cerevel Therapeutics has a diversified pipeline comprising five clinical-stage investigational therapies and several pre-clinical compounds with the potential to treat a range of neuroscience diseases, including Parkinsons, epilepsy, schizophrenia, and substance use disorder. Headquartered in Cambridge, Mass., Cerevel Therapeutics is advancing its current research and development programs while exploring new modalities through internal research efforts, external collaborations, or potential acquisitions. For more information, visit http://www.cerevel.com.
Story continues
Special Note Regarding Forward-Looking StatementsThis press release contains forward-looking statements that are based on managements beliefs and assumptions and on information currently available to management. In some cases, you can identify forward-looking statements by the following words: may, will, could, would, should, expect, intend, plan, anticipate, believe, estimate, predict, project, potential, continue, ongoing or the negative of these terms or other comparable terminology, although not all forward-looking statements contain these words. These statements involve risks, uncertainties and other factors that may cause actual results, levels of activity, performance, or achievements to be materially different from the information expressed or implied by these forward-looking statements. Although we believe that we have a reasonable basis for each forward-looking statement contained in this press release, we caution you that these statements are based on a combination of facts and factors currently known by us and our projections of the future, about which we cannot be certain. Forward-looking statements in this press release include, but are not limited to, statements about our upcoming virtual investor conference participation and the potential attributes and benefits of our product candidates. We cannot assure you that the forward-looking statements in this press release will prove to be accurate. Furthermore, if the forward-looking statements prove to be inaccurate, the inaccuracy may be material. Actual performance and results may differ materially from those projected or suggested in the forward-looking statements due to various risks and uncertainties, including, among others: clinical trial results may not be favorable; uncertainties inherent in the product development process (including with respect to the timing of results and whether such results will be predictive of future results); the impact of COVID-19 on the timing, progress and results of ongoing or planned clinical trials; other impacts of COVID-19, including operational disruptions or delays or to our ability to raise additional capital; whether and when, if at all, our product candidates will receive approval from the FDA or other regulatory authorities, and for which, if any, indications; competition from other biotechnology companies; uncertainties regarding intellectual property protection; and other risks identified in our SEC filings, including those under the heading Risk Factors in our Quarterly Report on Form 10-Q filed with the SEC on August 11, 2021 and our subsequent SEC filings. In light of the significant uncertainties in these forward-looking statements, you should not regard these statements as a representation or warranty by us or any other person that we will achieve our objectives and plans in any specified time frame, or at all. The forward-looking statements in this press release represent our views as of the date of this press release. We anticipate that subsequent events and developments will cause our views to change. However, while we may elect to update these forward-looking statements at some point in the future, we have no current intention of doing so except to the extent required by applicable law. You should, therefore, not rely on these forward-looking statements as representing our views as of any date subsequent to the date of this press release.
Media Contact:Kate ContrerasReal Chemistrykcontreras@realchemistry.com
Investor Contact:Matthew CalistriCerevel Therapeuticsmatthew.calistri@cerevel.com
See the original post here:
Cerevel Therapeutics to Participate at Upcoming Virtual Investor Conferences - Yahoo Finance
- New neuroscience research sheds light on distinct patterns of learning and generalization in autistic adults - PsyPost - January 23rd, 2025 [January 23rd, 2025]
- Neuroscientists need to do better at explaining basic mental health research - The Transmitter: Neuroscience News and Perspectives - January 23rd, 2025 [January 23rd, 2025]
- How Severance shows the possibilities of cognitive neuroscience - Fast Company - January 23rd, 2025 [January 23rd, 2025]
- AdventHealth Welcomes New Leadership In Heart and Vascular Services, Neuroscience and Orthopedics - Northwest Georgia News - January 23rd, 2025 [January 23rd, 2025]
- School of Neuroscience and Language Sciences Program recognized with University Exemplary Department or Program Award - Virginia Tech - January 23rd, 2025 [January 23rd, 2025]
- Early Exposure to Violent Media Linked to Teen Antisocial Behavior - Neuroscience News - January 23rd, 2025 [January 23rd, 2025]
- The Real Cognitive Neuroscience Behind Severance - WIRED - January 23rd, 2025 [January 23rd, 2025]
- The 15 most popular psychology and neuroscience studies in 2024 - PsyPost - January 1st, 2025 [January 1st, 2025]
- The 'lizard brain' lie: How neuroscience demolished the greatest mind myth - BBC Science Focus - January 1st, 2025 [January 1st, 2025]
- Revolutionizing Brain Diagnostics with Light and AI - Neuroscience News - January 1st, 2025 [January 1st, 2025]
- How Early Experiences Shape Genes, Brain Health, and Resilience - Neuroscience News - January 1st, 2025 [January 1st, 2025]
- A nation exhausted: The neuroscience of why Americans are tuning out political news - Indiana Capital Chronicle - January 1st, 2025 [January 1st, 2025]
- Lithium Restores Brain Function and Behavior in Autism - Neuroscience News - January 1st, 2025 [January 1st, 2025]
- Partners in Diversity presents the science of belonging: exploring the neuroscience of inclusion - Here is Oregon - January 1st, 2025 [January 1st, 2025]
- Classical vs. Operant Conditioning: The Brain's Memory Tug-of-War - Neuroscience News - January 1st, 2025 [January 1st, 2025]
- The Personality Gap Between Singles and the Partnered - Neuroscience News - January 1st, 2025 [January 1st, 2025]
- The Neuroscience Behind Vermeers Girl and Its Hypnotic Power - ZME Science - January 1st, 2025 [January 1st, 2025]
- Serotonin, GABA, and Dopamine Drive Hunger and Feeding - Neuroscience News - December 23rd, 2024 [December 23rd, 2024]
- A nation exhausted: The neuroscience of why Americans are tuning out politics - The Conversation - December 23rd, 2024 [December 23rd, 2024]
- UNO Goalie and Neuroscience Grad Shines in Her Athletic and Academic Aspirations - University of Nebraska Omaha - December 23rd, 2024 [December 23rd, 2024]
- Neuroscience Major Seeks to Bridge the Generation Gap, Help Alzheimers Patients - Pomona College - December 23rd, 2024 [December 23rd, 2024]
- Spectrum 2024: Year in review - The Transmitter: Neuroscience News and Perspectives - December 23rd, 2024 [December 23rd, 2024]
- Say what? The Transmitters top quotes of 2024 - The Transmitter: Neuroscience News and Perspectives - December 23rd, 2024 [December 23rd, 2024]
- Targeted or Broadcast? How the Brain Processes Visual Information - Neuroscience News - December 23rd, 2024 [December 23rd, 2024]
- 70 Is the New 60: Age Related Declines Slowing in Older People - Neuroscience News - December 23rd, 2024 [December 23rd, 2024]
- Breathing Rhythms During Sleep Strengthen Memory Consolidation - Neuroscience News - December 23rd, 2024 [December 23rd, 2024]
- How our brains think: Exploring the world of neuroscience at the Yale Peabody Museum - Connecticut Public - December 23rd, 2024 [December 23rd, 2024]
- Assembloids illuminate circuit-level changes linked to autism, neurodevelopment - The Transmitter: Neuroscience News and Perspectives - December 23rd, 2024 [December 23rd, 2024]
- Mapping the Brain's Response to Social Rejection - Neuroscience News - December 9th, 2024 [December 9th, 2024]
- An eye for science: Q&A with Bryan W. Jones - The Transmitter: Neuroscience News and Perspectives - December 9th, 2024 [December 9th, 2024]
- Short Sleep and High Blood Pressure Linked to Brain Aging - Neuroscience News - December 9th, 2024 [December 9th, 2024]
- Neighborhood Disadvantage Linked to Cognitive Health Risks - Neuroscience News - December 9th, 2024 [December 9th, 2024]
- Psychosis Risk Tied to Heavy Cannabis Use and Genetic Factors - Neuroscience News - December 9th, 2024 [December 9th, 2024]
- Most Teens Recover From Long Covid Within Two Years - Neuroscience News - December 9th, 2024 [December 9th, 2024]
- Opportunities and challenges of single-cell and spatially resolved genomics methods for neuroscience discovery - Nature.com - December 9th, 2024 [December 9th, 2024]
- How Evolution Shaped the Brains Understanding of Numbers - Neuroscience News - December 9th, 2024 [December 9th, 2024]
- Neuroscience Study Aboard Cunard's Queen Mary 2 Reveals Cognitive Benefits of Slow Travel at Sea - PR Newswire - November 28th, 2024 [November 28th, 2024]
- How Expectations Shape Our Gaze in a Changing World - Neuroscience News - November 28th, 2024 [November 28th, 2024]
- To keep or not to keep: Neurophysiologys data dilemma - The Transmitter: Neuroscience News and Perspectives - November 28th, 2024 [November 28th, 2024]
- Does Alcohol Consumption Contribute to Hair Loss? - Neuroscience News - November 28th, 2024 [November 28th, 2024]
- Brains Traffic Controllers Hold Key to Learning and Memory - Neuroscience News - November 28th, 2024 [November 28th, 2024]
- Despite Neuroscience Setback, AbbVie Has Strong Recovery Ahead (ABBV) - Seeking Alpha - November 28th, 2024 [November 28th, 2024]
- Neuroscientists reeling from past cuts advocate for more BRAIN Initiative funding - The Transmitter: Neuroscience News and Perspectives - November 28th, 2024 [November 28th, 2024]
- Want Better Habits? Neuroscience Says This Is How to Train Your Brain - Inc. - November 28th, 2024 [November 28th, 2024]
- Dopamine and Serotonin Work in Opposition for Effective Learning - Neuroscience News - November 28th, 2024 [November 28th, 2024]
- Cunard Proves the Healing Power of Ocean Travel with Breakthrough Neuroscience Research - Travel And Tour World - November 28th, 2024 [November 28th, 2024]
- Bridging the Gap between Meditation, Neuroscience, and the Soul - openPR - November 28th, 2024 [November 28th, 2024]
- Animal Characters in Childrens Books Boost Theory of Mind - Neuroscience News - November 28th, 2024 [November 28th, 2024]
- Emotional Struggles and Tantrums in Preschoolers Linked to ADHD - Neuroscience News - November 28th, 2024 [November 28th, 2024]
- Neuroscience Says This Simple Habit Improves Cognitive Health and Makes Your Brain Act Younger - Inc. - November 20th, 2024 [November 20th, 2024]
- Premature declarations on animal consciousness hinder progress - The Transmitter: Neuroscience News and Perspectives - November 20th, 2024 [November 20th, 2024]
- Medtronic Q2 Earnings: Diabetes And Neuroscience Revenue Boost Growth, Raises Annual Outlook - Yahoo Finance - November 20th, 2024 [November 20th, 2024]
- Trace Neuroscience Nets $101M in Series A Funding for ALS, Dementia Therapy Development - Senior Housing News - November 20th, 2024 [November 20th, 2024]
- How to be a multidisciplinary neuroscientist - The Transmitter: Neuroscience News and Perspectives - November 20th, 2024 [November 20th, 2024]
- Neuroscience Market Expected to Reach USD 71.0 Billion by - GlobeNewswire - November 20th, 2024 [November 20th, 2024]
- Finger-Prick Test Brings Alzheimers Detection Closer to Everyone - Neuroscience News - November 20th, 2024 [November 20th, 2024]
- Dual-Gene Therapy Shows Promise for Hearing and Vision Loss - Neuroscience News - November 20th, 2024 [November 20th, 2024]
- Robots Help Unlock the Mystery of Human Sense of Self - Neuroscience News - November 20th, 2024 [November 20th, 2024]
- The neuroscience of sleep - University of South Carolina - November 20th, 2024 [November 20th, 2024]
- Stress warps fear memories in multiple ways - The Transmitter: Neuroscience News and Perspectives - November 20th, 2024 [November 20th, 2024]
- Mental Exhaustion Drives Aggressive Behavior - Neuroscience News - November 12th, 2024 [November 12th, 2024]
- NeuroAI: A field born from the symbiosis between neuroscience, AI - The Transmitter: Neuroscience News and Perspectives - November 12th, 2024 [November 12th, 2024]
- The neuroscience of deeper learning in math - SmartBrief - November 12th, 2024 [November 12th, 2024]
- What the brain can teach artificial neural networks - The Transmitter: Neuroscience News and Perspectives - November 12th, 2024 [November 12th, 2024]
- How Anthony Zador thinks neuroscience can help improve AI - The Transmitter: Neuroscience News and Perspectives - November 12th, 2024 [November 12th, 2024]
- Discovering Cancer Therapies through Neuroscience - The New York Academy of Sciences - November 12th, 2024 [November 12th, 2024]
- Neuroscience Market Projected to Reach USD 50.2 Billion by 2032, Growing at a 4.0% CAGR S&S Insider - GlobeNewswire - November 12th, 2024 [November 12th, 2024]
- Insights on Brain Aging and Lifelong Cognitive Health - Neuroscience News - November 12th, 2024 [November 12th, 2024]
- A neuroscience PhD student at the University of Oxford has died - The Tab - November 12th, 2024 [November 12th, 2024]
- Exploring the connection between autism and sleep - The Transmitter: Neuroscience News and Perspectives - November 12th, 2024 [November 12th, 2024]
- Astrocytes star in memory storage, recall - The Transmitter: Neuroscience News and Perspectives - November 12th, 2024 [November 12th, 2024]
- Gut Bacteria Modulate Stress Responses Over Time - Neuroscience News - November 12th, 2024 [November 12th, 2024]
- Gut Bacteria Could Hold the Key to Promoting Healthy Aging - Neuroscience News - November 12th, 2024 [November 12th, 2024]
- Microglias pruning function called into question - The Transmitter: Neuroscience News and Perspectives - October 26th, 2024 [October 26th, 2024]
- Depression Alters Brain Circuits, Heightening Negative Perception - Neuroscience News - October 26th, 2024 [October 26th, 2024]
- UNE Researchers Showcase Groundbreaking Work at Global Neuroscience Conference - University of New England - October 26th, 2024 [October 26th, 2024]
- Scientists discover "glue" that holds memory together in fascinating neuroscience breakthrough - PsyPost - October 26th, 2024 [October 26th, 2024]
- Systems neuroscience: combining theory and neurotechnology for a multiscale account of the brain - Nature.com - October 26th, 2024 [October 26th, 2024]
- Seaport Therapeutics adds another $225 million to coffers to embrace the golden age of neuroscience - STAT - October 26th, 2024 [October 26th, 2024]
- ANRO Investors Have Opportunity to Join Alto Neuroscience, Inc. Fraud Investigation with the Schall Law Firm - Business Wire - October 26th, 2024 [October 26th, 2024]